The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2022 | Treatment approaches for older patients with MCL
In this video, Jia Ruan, MD, PhD, Weill Cornell Medicine, New York, NY, shares some insights into treatment approaches for older patients with mantle cell lymphoma (MCL), highlighting the value of chemotherapy-free regimens. Dr Ruan then goes on to discuss various Phase II and Phase III clinical trials evaluating these regimens, including ibrutinib in combination with rituximab, and zanubrutinib in combination with rituximab. This interview took place at the Tenth Annual Meeting of the Society of Hematologic Oncology (SOHO) held in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
